225 related articles for article (PubMed ID: 34488613)
21. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.
Polhemus DJ; Lefer DJ
Circ Res; 2014 Feb; 114(4):730-7. PubMed ID: 24526678
[TBL] [Abstract][Full Text] [Related]
22. Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.
Wallace JL; Vaughan D; Dicay M; MacNaughton WK; de Nucci G
Antioxid Redox Signal; 2018 Jun; 28(16):1533-1540. PubMed ID: 28388861
[TBL] [Abstract][Full Text] [Related]
23. Hydrogen sulfide prodrugs-a review.
Zheng Y; Ji X; Ji K; Wang B
Acta Pharm Sin B; 2015 Sep; 5(5):367-77. PubMed ID: 26579468
[TBL] [Abstract][Full Text] [Related]
24. Hydrogen Sulfide and its Interaction with Other Players in Inflammation.
Manandhar S; Sinha P; Ejiwale G; Bhatia M
Adv Exp Med Biol; 2021; 1315():129-159. PubMed ID: 34302691
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide: a target to modulate oxidative stress and neuroplasticity for the treatment of pathological anxiety.
Chen M; Pritchard C; Fortune D; Kodi P; Grados M
Expert Rev Neurother; 2020 Jan; 20(1):109-121. PubMed ID: 31530193
[No Abstract] [Full Text] [Related]
26. A Review of Patents on Therapeutic Potential and Delivery of Hydroge n Sulfide.
Verma R; Akhtar Y; Singh S
Recent Pat Drug Deliv Formul; 2017; 11(2):114-123. PubMed ID: 28901845
[TBL] [Abstract][Full Text] [Related]
27. Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure.
Donnarumma E; Trivedi RK; Lefer DJ
Compr Physiol; 2017 Mar; 7(2):583-602. PubMed ID: 28333381
[TBL] [Abstract][Full Text] [Related]
28. Esterase-Sensitive Prodrugs with Tunable Release Rates and Direct Generation of Hydrogen Sulfide.
Zheng Y; Yu B; Ji K; Pan Z; Chittavong V; Wang B
Angew Chem Int Ed Engl; 2016 Mar; 55(14):4514-8. PubMed ID: 26822005
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.
Wallace JL; Blackler RW; Chan MV; Da Silva GJ; Elsheikh W; Flannigan KL; Gamaniek I; Manko A; Wang L; Motta JP; Buret AG
Antioxid Redox Signal; 2015 Feb; 22(5):398-410. PubMed ID: 24635322
[TBL] [Abstract][Full Text] [Related]
30. Signaling of hydrogen sulfide and polysulfides.
Kimura H
Antioxid Redox Signal; 2015 Feb; 22(5):347-9. PubMed ID: 25178405
[TBL] [Abstract][Full Text] [Related]
31. Near-infrared fluorescent chemodosimeter for real-time in vivo evaluation of H
Yao X; Liu W; Zhu W; Tiemuer A; Zhou F; Yang S; Yu H; Qian X; Liu Y
Chem Commun (Camb); 2020 Jul; 56(58):8111-8114. PubMed ID: 32555858
[TBL] [Abstract][Full Text] [Related]
32. Analytical Methods for Detection of Gasotransmitter Hydrogen Sulfide Released from Live Cells.
Quan FS; Lee GJ
Biomed Res Int; 2021; 2021():5473965. PubMed ID: 34497847
[TBL] [Abstract][Full Text] [Related]
33. Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.
Chen Y; Yuan S; Cao Y; Kong G; Jiang F; Li Y; Wang Q; Tang M; Zhang Q; Wang Q; Liu L
Oxid Med Cell Longev; 2021; 2021():3206982. PubMed ID: 34594474
[TBL] [Abstract][Full Text] [Related]
34. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.
Kang SC; Sohn EH; Lee SR
Oxid Med Cell Longev; 2020; 2020():4105382. PubMed ID: 32064023
[TBL] [Abstract][Full Text] [Related]
36. The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease.
Wen YD; Wang H; Zhu YZ
Oxid Med Cell Longev; 2018; 2018():4010395. PubMed ID: 30151069
[TBL] [Abstract][Full Text] [Related]
37. Using hydrogen sulfide to design and develop drugs.
Calderone V; Martelli A; Testai L; Citi V; Breschi MC
Expert Opin Drug Discov; 2016; 11(2):163-75. PubMed ID: 26593865
[TBL] [Abstract][Full Text] [Related]
38. Spectroscopic investigation of the reaction of metallo-protoporphyrins with hydrogen sulfide.
Hartle MD; Tillotson MR; Prell JS; Pluth MD
J Inorg Biochem; 2017 Aug; 173():152-157. PubMed ID: 28551529
[TBL] [Abstract][Full Text] [Related]
39. Hydrogels for Gasotransmitter Delivery: Nitric Oxide, Carbon Monoxide, and Hydrogen Sulfide.
Sarkar S; Kumar R; Matson JB
Macromol Biosci; 2024 Jan; 24(1):e2300138. PubMed ID: 37326828
[TBL] [Abstract][Full Text] [Related]
40. Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19.
Dominic P; Ahmad J; Bhandari R; Pardue S; Solorzano J; Jaisingh K; Watts M; Bailey SR; Orr AW; Kevil CG; Kolluru GK
Redox Biol; 2021 Jul; 43():101982. PubMed ID: 34020311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
